04/23 | ROCHE : New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions.. | BU |
04/18 | GSK flags pharma M&A ambitions by poaching Roche deal-maker | RE |
04/18 | Shire faces criticism on CEO pay policy as crunch week looms | RE |
04/17 | ROCHE : FDA Grants Breakthrough Therapy Designation for Genentech’s HEMLIB.. | BU |
04/16 | GENENTECH : to Present New Data at AAN Highlighting Extensive Research for OCREV.. | BU |
04/09 | Novartis bets big on gene therapy with $8.7 billion AveXis deal | RE |
04/09 | Novartis bets big on gene therapy with $8.7 billion AveXis deal | RE |
04/09 | Novartis bets big on gene therapy with $8.7 billion AveXis deal | RE |
04/03 | Roche's Alecensa Approved in Switzerland | DJ |
03/28 | ROCHE : Tokyo court rejects Shire claim against Roche haemophilia drug | RE |
03/26 | Singapore pharma on recovery path after worst output in decades | RE |
03/26 | Roche's Tecentriq Improves Lung Cancer Treatment Results With Avastin | DJ |
03/26 | ROCHE : Phase III IMpower150 Study Showed Genentech’s TECENTRIQ (Atezolizu.. | BU |
03/22 | Roche's Lucentis 0.3 Mg Prefilled Syringe Receives FDA Approval | DJ |
03/21 | Britain's use of copycat biotech drugs takes off while U.S. lags | RE |
03/21 | ROCHE : FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg P.. | BU |
03/21 | GlaxoSmithKline prescribes commercial reboot for pharma division | RE |
03/21 | GlaxoSmithKline prescribes commercial reboot for pharma division | RE |
03/20 | Roche says Tecentriq, chemo cut risk of death in type of lung cancer | RE |
03/20 | ROCHE : Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizu.. | BU |
03/19 | GLOBAL ARTIFICIAL INTELLIGENCE AND A : Global Artificial Intelligence And Advanc.. | AQ |
03/19 | PTC THERAPEUTICS : FIREFISH Transitions into Pivotal Phase | AQ |
03/19 | FOUNDATION MEDICINE : CMS issues final coverage decision for NGS cancer tests | AQ |
03/17 | ROCHE : Federal Contracts Awarded to Companies in Indiana (March 17) | AQ |
03/17 | ROCHE : Federal Contracts Awarded by Federal Agencies in North Dakota (March 17) | AQ |
03/16 | KNOW ABOUT CERVICAL CANCER MARKET IN : New Research: Cervical Cancer Market &nda.. | AQ |
03/16 | ROCHE : Q-- 6 month Bridge ROCHE - IOWA CITY | AQ |
03/16 | ROCHE : Q-- 6 month Bridge ROCHE - DES MOINES | AQ |
03/16 | ROCHE : $1.31 Million Federal Contract Awarded to Roche Diagnostics | AQ |
03/16 | ROCHE : Vintage Drawer Pulls and Handles Bring High Aesthetics to Every Home | AQ |
03/16 | ROCHE : $432,000 Federal Contract Awarded to Roche Diagnostics | AQ |
03/16 | ROCHE : $375,000 Federal Contract Awarded to Roche Diagnostics | AQ |
03/15 | FOUNDATION MEDICINE : Tango Therapeutics Expands Board of Directors with the Add.. | AQ |
03/15 | FOUNDATION MEDICINE : to Present at Cowen and Company's 38th Annual Healthcare C.. | AQ |
03/15 | ROCHE HOLDING LTD. : Ex-dividend day for for final dividend | FA |
03/14 | CURIS : Reports Fourth Quarter and Year-End 2017 Financial Results | AQ |
03/14 | ROCHE : BioMed X and Roche announce research collaboration | AQ |
03/10 | CELGENE : Kapeller leaves Nimbus, ending CSO stint defined by virtual drug disco.. | AQ |
03/10 | ROCHE : names new head of pharma research and early development | AQ |
03/09 | ROCHE : Changes to the Roche Enlarged Corporate Executive Committee | AQ |
03/08 | CHUGAI PHARMACEUTICAL : HEMLIBRA® Approved by European Commission in Hemophilia .. | AQ |
03/08 | ROCHE : names Pao as Swiss R&D head after Reed exits | RE |
03/08 | ROCHE : Names New Head of Pharma Research and Early Development | DJ |
03/07 | FOUNDATION MEDICINE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO.. | AQ |
03/07 | FOUNDATION MEDICINE : reports 4Q loss | AQ |
03/07 | FOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Finan.. | AQ |
03/07 | ROCHE : GE to Develop Integrated Decision Support Platform | AQ |
03/07 | Siemens' Healthineers share listing fully subscribed - bookrunner | RE |
03/07 | CIPLA : To Sell Two Roche Biologics In India | AQ |
03/06 | PEOPLE BEFORE PROFITS : Roche’s innovative employment practices | AQ |
03/06 | Glaxo's Encouraging Asthma & HIV Data at Medical Meetings | AQ |
03/05 | ROCHE : Refuse skips | AQ |
03/05 | FOUNDATION MEDICINE, INC. : Entry into a Material Definitive Agreement (form 8-K.. | AQ |
03/05 | ROCHE : Trial drug given `accelerated status` paves way for faster approval | AQ |
03/03 | MetroWest Business Digest for March 4, 2018 | AQ |
03/03 | IONIS PHARMACEUTICALS : drug for Huntington's disease shows early signs of effec.. | AQ |
03/02 | ROCHE : achieves two major milestones in the evolution of decision support platf.. | PR |
03/02 | CIPLA : partners with Roche Pharma India to create greater access to key medicin.. | AQ |
03/02 | CHUGAI PHARMACEUTICAL : HEMLIBRA Approved by European Commission in Hemophilia A.. | AQ |
03/02 | ROCHE : Europe approves first therapy for haemophilia A with inhibitors in over .. | AQ |
03/02 | BIOMERIEUX : Six Leading Pharma Firms to Participate at Pharmaceutical Microbiol.. | AQ |
03/01 | BIOMERIEUX : Six leading pharma firms to participate at Pharmaceutical Microbiol.. | AQ |
03/01 | CIPLA : Roche and Cipla tie up to market anti cancer drugs | AQ |
03/01 | ROCHE : Chugais Hemlibra wins green light for bleeding disorder | AQ |
03/01 | PFIZER : Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development.. | AQ |
03/01 | Cipla, roche in first deal to sell cancer drugs | AQ |
02/28 | GLOBAL BIOLOGICS AND BIOSIMILARS MAR : 99strategy added a depth and professional.. | AQ |
02/28 | BIOMERIEUX : Six leading pharma firms to participate at Pharmaceutical Microbiol.. | AQ |
02/28 | ROCHE : European Commission approves Roche's Hemlibra for people with haemophili.. | AQ |
02/28 | TESARO : Announces Collaboration to Evaluate Combination of ZEJULA (Niraparib) a.. | AQ |
02/28 | TESARO : and Roche to combine drugs in bladder cancer trials | AQ |
02/28 | CIPLA : To sell 2 roche drugs in india | AQ |
02/27 | SHIONOGI : New Japanese drug halts flu virus replication in 1 day | AQ |
02/27 | TESARO : Announces Collaboration to Evaluate Combination of ZEJULA and Anti-PD-L.. | AQ |
02/27 | ROCHE : LAUNCHES MASS-MARKET GLUCOMETER AT Rs1,099 | AQ |